PANACEA BIOTEC
Quarterly Results Analysis [Jun2025]
PANACEA BIOTEC Quarterly Results
Consolidated | Jun2025 UnAudited |
Mar2025 UnAudited |
Dec2024 UnAudited |
Sep2024 UnAudited |
Jun2024 UnAudited |
Mar2024 UnAudited |
Dec2023 UnAudited |
Sep2023 Audited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹167 Cr | ₹133 Cr | ₹163 Cr | ₹147 Cr | ₹116 Cr | ₹136 Cr | ₹151 Cr | ₹143 Cr |
Expenses | ₹168 Cr | ₹159 Cr | ₹156 Cr | ₹140 Cr | ₹130 Cr | ₹143 Cr | ₹151 Cr | ₹147 Cr |
Operating Income | ₹-1 Cr | ₹-27 Cr | ₹8 Cr | ₹7 Cr | ₹-14 Cr | ₹-6 Cr | ₹0 Cr | ₹-4 Cr |
Other Income | ₹6 Cr | ₹9 Cr | ₹4 Cr | ₹5 Cr | ₹4 Cr | ₹11 Cr | ₹6 Cr | ₹3 Cr |
Interest | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr |
Depreciation | ₹8 Cr | ₹8 Cr | ₹9 Cr | ₹9 Cr | ₹9 Cr | ₹9 Cr | ₹9 Cr | ₹9 Cr |
Profit Before Tax | ₹7 Cr | ₹0 Cr | ₹4 Cr | ₹5 Cr | ₹-17 Cr | ₹-2 Cr | ₹-2 Cr | ₹-8 Cr |
Profit After Tax | ₹4 Cr | ₹-2 Cr | ₹4 Cr | ₹5 Cr | ₹-16 Cr | ₹-2 Cr | ₹-2 Cr | ₹-8 Cr |
EPS | ₹0.66 | ₹-0.31 | ₹0.74 | ₹0.78 | ₹-2.58 | ₹-0.23 | ₹-0.37 | ₹-1.37 |
Industry Peers & Returns | 1W | 1M | 1Y |
PANACEA BIOTEC | -1.1% | 2% | 69.4% |
SUN PHARMACEUTICAL INDUSTRIES | 1% | -0.2% | -13.4% |
DIVIS LABORATORIES | -2.7% | -2.2% | 17.6% |
CIPLA | -1.7% | 4.1% | -5.3% |
TORRENT PHARMACEUTICALS | 1% | 1.3% | 4.9% |
DR REDDYS LABORATORIES | 2.5% | 7.7% | -6.7% |
MANKIND PHARMA | 1.2% | 1.9% | 4.4% |
ZYDUS LIFESCIENCES | 2.8% | 9.7% | -9.5% |
LUPIN | 0.4% | 0.7% | -14.9% |
PANACEA BIOTEC Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | 25.78 % |
Y-o-Y | 44.05 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Jun2025 | ₹167 Cr | 25.78 | |
Mar2025 | ₹133 Cr | -18.94 | |
Dec2024 | ₹163 Cr | 10.95 | |
Sep2024 | ₹147 Cr | 27.33 | |
Jun2024 | ₹116 Cr | -15.20 | |
Mar2024 | ₹136 Cr | -9.33 | |
Dec2023 | ₹151 Cr | 5.23 | |
Sep2023 | ₹143 Cr | - |
PANACEA BIOTEC Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | Negative |
Y-o-Y | Negative |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Jun2025 | ₹-1 Cr | Negative | |
Mar2025 | ₹-27 Cr | Negative | |
Dec2024 | ₹8 Cr | 13.71 | |
Sep2024 | ₹7 Cr | Positive | |
Jun2024 | ₹-14 Cr | Negative | |
Mar2024 | ₹-6 Cr | Negative | |
Dec2023 | ₹0 Cr | Negative | |
Sep2023 | ₹-4 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | Negative |
Y-o-Y | Negative |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Jun2025 | -0.71% | Negative | |
Mar2025 | -20.28% | Negative | |
Dec2024 | 4.87% | 2.53 | |
Sep2024 | 4.75% | Positive | |
Jun2024 | -12.09% | Negative | |
Mar2024 | -4.43% | Negative | |
Dec2023 | -0.1% | Negative | |
Sep2023 | -2.49% | - |
PANACEA BIOTEC Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | Positive |
Y-o-Y | Positive |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Jun2025 | ₹4 Cr | Positive | |
Mar2025 | ₹-2 Cr | Negative | |
Dec2024 | ₹4 Cr | -5.73 | |
Sep2024 | ₹5 Cr | Positive | |
Jun2024 | ₹-16 Cr | Negative | |
Mar2024 | ₹-2 Cr | Negative | |
Dec2023 | ₹-2 Cr | Negative | |
Sep2023 | ₹-8 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | Positive |
Y-o-Y | Positive |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Jun2025 | 2.38 % | Positive | |
Mar2025 | -1.5 % | Negative | |
Dec2024 | 2.72 % | -15.00 | |
Sep2024 | 3.2 % | Positive | |
Jun2024 | -13.72 % | Negative | |
Mar2024 | -1.46 % | Negative | |
Dec2023 | -1.46 % | Negative | |
Sep2023 | -5.8 % | - |
PANACEA BIOTEC Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | Positive |
Y-o-Y | Positive |
Quarters | EPS | % Change | |
---|---|---|---|
Jun2025 | ₹0.66 | Positive | |
Mar2025 | ₹-0.31 | Negative | |
Dec2024 | ₹0.74 | -5.13 | |
Sep2024 | ₹0.78 | Positive | |
Jun2024 | ₹-2.58 | Negative | |
Mar2024 | ₹-0.23 | Negative | |
Dec2023 | ₹-0.37 | Negative | |
Sep2023 | ₹-1.37 | - |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs MANKIND PHARMA LTD